John Srouji

463 total citations
3 papers, 44 citations indexed

About

John Srouji is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, John Srouji has authored 3 papers receiving a total of 44 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Immunology, 2 papers in Oncology and 1 paper in Radiology, Nuclear Medicine and Imaging. Recurrent topics in John Srouji's work include Immunotherapy and Immune Responses (3 papers), T-cell and B-cell Immunology (2 papers) and CAR-T cell therapy research (1 paper). John Srouji is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), T-cell and B-cell Immunology (2 papers) and CAR-T cell therapy research (1 paper). John Srouji collaborates with scholars based in United States. John Srouji's co-authors include Michael S. Rooney, Richard B. Gaynor, Jennifer G. Abelin, Daniel Rothenberg, Terri A. Addona, Vikram R. Juneja, Scott P. Goulding, Marit M. van Buuren, Jesse Z. Dong and Meghan E. Bushway and has published in prestigious journals such as Cancer Research and Cell Reports Methods.

In The Last Decade

John Srouji

3 papers receiving 42 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Srouji United States	3	34	27	19	11	2	3	44
Chrysa Papadopoulou Switzerland	4	46 1.4×	19 0.7×	28 1.5×	7 0.6×	2 1.0×	4	62
Gwendoline Grondin France	3	54 1.6×	47 1.7×	13 0.7×	11 1.0×		3	67
Loes Plaisier Netherlands	2	24 0.7×	23 0.9×	15 0.8×	20 1.8×	1 0.5×	2	45
Jannes Govaerts Belgium	4	44 1.3×	33 1.2×	20 1.1×	4 0.4×	2 1.0×	5	62
Hamid Khoja	2	39 1.1×	45 1.7×	24 1.3×	10 0.9×		3	60
Hannah Reimann Germany	2	24 0.7×	27 1.0×	9 0.5×	7 0.6×	2 1.0×	8	36
Georges Bedran Poland	3	28 0.8×	19 0.7×	30 1.6×	6 0.5×		8	46
Andrea Mahr Germany	2	22 0.6×	18 0.7×	17 0.9×	4 0.4×		2	28
Tina Weinzierl Switzerland	4	16 0.5×	32 1.2×	26 1.4×	29 2.6×		4	52
Jeffrey Eastham United States	5	23 0.7×	16 0.6×	12 0.6×	6 0.5×	1 0.5×	7	49

Countries citing papers authored by John Srouji

Since Specialization

Citations

This map shows the geographic impact of John Srouji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Srouji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Srouji more than expected).

Fields of papers citing papers by John Srouji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Srouji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Srouji. The network helps show where John Srouji may publish in the future.

Co-authorship network of co-authors of John Srouji

This figure shows the co-authorship network connecting the top 25 collaborators of John Srouji. A scholar is included among the top collaborators of John Srouji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Srouji. John Srouji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Kohler, Victoria, Ekaterina Esaulova, Dewi Harjanto, et al.. (2023). A universal MHCII technology platform to characterize antigen-specific CD4+ T cells. Cell Reports Methods. 3(1). 100388–100388. 6 indexed citations

2.

Goulding, Scott P., Daniel Rothenberg, John Srouji, et al.. (2021). Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutations. Cell Reports Methods. 1(5). 100084–100084. 34 indexed citations

3.

Awad, Mark M., Ramaswamy Govindan, David R. Spigel, et al.. (2021). Abstract 73: A personal neoantigen vaccine NEO-PV-01 in combination with chemotherapy and pembrolizumab induces broad de novo immune responses in first-line non-squamous NSCLC: Associations with clinical outcomes. Cancer Research. 81(13_Supplement). 73–73. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact